Connect with us

Health

MEPs supportive of draft Biotech report, but divisions over incentives remain

SHARE:

Published

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The European Parliament's first debate on its draft  Biotech Act report showed broad political support for strengthening Europe's biotechnology sector, while exposing disagreements over how best to boost innovation, streamline clinical trials and incentivize investment.

Presenting their joint report, co-rapporteurs Wouter Beke MEP (EPP, Belgium) from the Industry, Research and Energy (ITRE) committee and Vytenis Andriukaitis MEP (S&D, Lithuania) from the Public Health (SANT) committee argued the legislation should position Europe as a global biotechnology leader by linking competitiveness with better patient access.

Beke warned that Europe is steadily losing ground to the United States and China in venture capital, clinical trials, manufacturing and commercialization, arguing that biotechnology has become "deeply geopolitical"....

Share this article:

Share this:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.

Trending